
SBCEF-1GM Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
SBCEF-1GM
Ceftriaxone Sodium 1000mg Injection
SBCEF-1GM (Ceftriaxone Sodium 1000mg Injection) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in SBCEF-1GM deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store between 2°C to 8°C or below 25°C as indicated on label. Protect from light.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
SBCEF-1GM features Ceftriaxone Sodium 1000mg Injection prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Tracked for therapeutic compliance for SBCEF-1GM
SBCEF-1GM has been tracked for therapeutic compliance across diverse adult cohorts, with attending physicians reporting swift symptom reduction across outpatients. The secondary carton board quality is heavy and durable, protecting contents from transport shock. Zero supply interruptions and consistent batch quality make this a standout pharmaceutical line.
Questions Regarding SBCEF-1GM
What is the therapeutic indication and composition of SBCEF-1GM?
SBCEF-1GM contains Ceftriaxone Sodium 1000mg Injection indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for SBCEF-1GM?
SBCEF-1GM is supplied in tamper-evident Single Dose Sterile Vial with Ampoule & WFI, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for SBCEF-1GM?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SBCEF-1GM along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
SBCEF-1GM is categorized as Schedule H1 Prescription Drug with an introductory PCD franchise MOQ of 100 units per batch.





